Paychex's stock bounces after profit rises above expectations and outlook is raised
By Tomi Kilgore
Human-resources services company sees small businesses hiring employees at a moderate level
Shares of Paychex Inc. rose Wednesday after the provider of human-resources outsourcing services reported fiscal first-quarter profit that rose above expectations and nudged up its full-year outlook.
"Small and mid-sized businesses remain resilient in navigating the broader macro-economic environment, as our Small Business Employment Watch continues to report that small businesses are hiring workers at a moderate level and wage inflation continues to normalize along with overall inflation," Chief Executive John Gibson said.
The stock (PAYX) rose 0.9% in premarket trading, after closing Tuesday at a 12-week low.
Net income for the quarter to Aug. 31 rose to $419.2 million, or $1.16 a share, from $379.2 million, or $1.05 a share, in the same period a year ago.
Excluding nonrecurring items, adjusted earnings per share of $1.14 beat the FactSet consensus of $1.12.
Revenue grew 6.6% to $1.286 billion, a touch above the FactSet consensus of $1.284 billion.
For fiscal 2024, the company now expects adjusted EPS to increase in the range of 9% to 11% from the prior year, up from previous guidance for growth of 9% to 10%.
The current FactSet EPS consensus of $4.68 implies 9.6% growth.
The company, which had a market capitalization of $40.7 billion as of Tuesday's closing stock price, also raised its full-year outlook for interest on funds held for clients to a range of $140 million to $150 million, up from $135 million to $145 million.
Paychex's stock has slipped 2.5% year to date through Tuesday, while the S&P 500 SPX has gained 11.3%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-27-23 0914ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track